nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—ABCB1—lung cancer	0.203	1	CbGaD
Sparfloxacin—TOP2A—Teniposide—lung cancer	0.134	0.234	CbGbCtD
Sparfloxacin—TOP2A—Etoposide—lung cancer	0.0589	0.103	CbGbCtD
Sparfloxacin—TOP2A—Doxorubicin—lung cancer	0.0402	0.0703	CbGbCtD
Sparfloxacin—ABCC2—Paclitaxel—lung cancer	0.0306	0.0535	CbGbCtD
Sparfloxacin—ABCC2—Irinotecan—lung cancer	0.0302	0.0528	CbGbCtD
Sparfloxacin—ABCC2—Vinblastine—lung cancer	0.0268	0.0469	CbGbCtD
Sparfloxacin—ABCC2—Cisplatin—lung cancer	0.0246	0.043	CbGbCtD
Sparfloxacin—ABCC2—Etoposide—lung cancer	0.0242	0.0423	CbGbCtD
Sparfloxacin—ABCC2—Docetaxel—lung cancer	0.0221	0.0387	CbGbCtD
Sparfloxacin—ABCB1—Topotecan—lung cancer	0.0202	0.0352	CbGbCtD
Sparfloxacin—ABCB1—Gefitinib—lung cancer	0.0184	0.0322	CbGbCtD
Sparfloxacin—ABCC2—Doxorubicin—lung cancer	0.0165	0.0288	CbGbCtD
Sparfloxacin—ABCC2—Methotrexate—lung cancer	0.016	0.0279	CbGbCtD
Sparfloxacin—ABCB1—Vinorelbine—lung cancer	0.0142	0.0248	CbGbCtD
Sparfloxacin—ABCB1—Crizotinib—lung cancer	0.0113	0.0197	CbGbCtD
Sparfloxacin—ABCB1—Gemcitabine—lung cancer	0.011	0.0193	CbGbCtD
Sparfloxacin—ABCB1—Erlotinib—lung cancer	0.0109	0.019	CbGbCtD
Sparfloxacin—ABCB1—Paclitaxel—lung cancer	0.00998	0.0174	CbGbCtD
Sparfloxacin—ABCB1—Irinotecan—lung cancer	0.00984	0.0172	CbGbCtD
Sparfloxacin—ABCB1—Vinblastine—lung cancer	0.00875	0.0153	CbGbCtD
Sparfloxacin—ABCB1—Cisplatin—lung cancer	0.00802	0.014	CbGbCtD
Sparfloxacin—ABCB1—Etoposide—lung cancer	0.00788	0.0138	CbGbCtD
Sparfloxacin—ABCB1—Docetaxel—lung cancer	0.00721	0.0126	CbGbCtD
Sparfloxacin—ABCB1—Doxorubicin—lung cancer	0.00538	0.0094	CbGbCtD
Sparfloxacin—ABCB1—Methotrexate—lung cancer	0.00521	0.0091	CbGbCtD
Sparfloxacin—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.000438	0.097	CbGdCrCtD
Sparfloxacin—TOP2A—Irinotecan—Topotecan—lung cancer	0.000375	0.083	CbGdCrCtD
Sparfloxacin—TOP2A—Erlotinib—Gefitinib—lung cancer	0.000327	0.0725	CbGdCrCtD
Sparfloxacin—TOP2A—Topotecan—Irinotecan—lung cancer	0.000312	0.069	CbGdCrCtD
Sparfloxacin—TOP2A—Etoposide—Teniposide—lung cancer	0.00031	0.0686	CbGdCrCtD
Sparfloxacin—Gatifloxacin—ALB—lung cancer	0.000303	0.537	CrCbGaD
Sparfloxacin—TOP2A—Vindesine—Vinorelbine—lung cancer	0.000279	0.0617	CbGdCrCtD
Sparfloxacin—TOP2A—Podofilox—Teniposide—lung cancer	0.000236	0.0523	CbGdCrCtD
Sparfloxacin—TOP2A—Vindesine—Vinblastine—lung cancer	0.000223	0.0493	CbGdCrCtD
Sparfloxacin—TOP2A—Methotrexate—Pemetrexed—lung cancer	0.000222	0.0492	CbGdCrCtD
Sparfloxacin—TOP2A—Paclitaxel—Docetaxel—lung cancer	0.000219	0.0484	CbGdCrCtD
Sparfloxacin—TOP2A—Afatinib—Gefitinib—lung cancer	0.000214	0.0474	CbGdCrCtD
Sparfloxacin—TOP2A—Gefitinib—Erlotinib—lung cancer	0.00021	0.0465	CbGdCrCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—AHR—lung cancer	0.000194	0.00353	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—ABCC3—lung cancer	0.000192	0.00349	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—MYC—lung cancer	0.000191	0.00348	CbGpPWpGaD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000188	0.00343	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—EGFR—lung cancer	0.000187	0.0034	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000185	0.00337	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—UGT1A1—lung cancer	0.00018	0.00328	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	0.000176	0.00322	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—lung cancer	0.000176	0.00321	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—ADCY1—lung cancer	0.000173	0.00315	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—NFE2L2—lung cancer	0.000171	0.00311	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—TGFA—lung cancer	0.000163	0.00297	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	0.000157	0.00287	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—TP53—lung cancer	0.000157	0.00286	CbGpPWpGaD
Sparfloxacin—TOP2A—Vincristine—Vinorelbine—lung cancer	0.00015	0.0333	CbGdCrCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APP—lung cancer	0.000149	0.00272	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—lung cancer	0.000149	0.00271	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—CYP2A6—lung cancer	0.000147	0.00268	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—GCLC—lung cancer	0.000147	0.00268	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—ALDOA—lung cancer	0.000147	0.00268	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—lung cancer	0.000146	0.00265	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	0.000141	0.00257	CbGpPWpGaD
Sparfloxacin—TOP2A—Vinorelbine—Vinblastine—lung cancer	0.000141	0.0311	CbGdCrCtD
Sparfloxacin—TOP2A—Podofilox—Etoposide—lung cancer	0.00014	0.0311	CbGdCrCtD
Sparfloxacin—TOP2A—Teniposide—Etoposide—lung cancer	0.00014	0.0311	CbGdCrCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—lung cancer	0.00014	0.00256	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.00014	0.00255	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—ABCG2—lung cancer	0.000139	0.00253	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000135	0.00246	CbGpPWpGaD
Sparfloxacin—Levofloxacin—ABCB1—lung cancer	0.000133	0.235	CrCbGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—TF—lung cancer	0.000129	0.00235	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000128	0.00234	CbGpPWpGaD
Sparfloxacin—Ciprofloxacin—ABCB1—lung cancer	0.000128	0.227	CrCbGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—ENO1—lung cancer	0.000124	0.00225	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—NQO1—lung cancer	0.000123	0.00225	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—lung cancer	0.000121	0.00221	CbGpPWpGaD
Sparfloxacin—TOP2A—Vinblastine—Vinorelbine—lung cancer	0.000121	0.0268	CbGdCrCtD
Sparfloxacin—TOP2A—Vincristine—Vinblastine—lung cancer	0.00012	0.0266	CbGdCrCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—lung cancer	0.00012	0.00218	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—lung cancer	0.000119	0.00217	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	0.000112	0.00205	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—AVP—lung cancer	0.000111	0.00203	CbGpPWpGaD
Sparfloxacin—ABCB1—ABC-family proteins mediated transport—APOA1—lung cancer	0.000111	0.00202	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	0.00011	0.00201	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TYMS—lung cancer	0.000106	0.00193	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	0.000104	0.0019	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—lung cancer	0.000103	0.00188	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—GSTP1—lung cancer	0.000103	0.00188	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000102	0.00187	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—FOXM1—lung cancer	0.000102	0.00187	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000101	0.00185	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	0.000101	0.00184	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—lung cancer	9.87e-05	0.0018	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—GSTM1—lung cancer	9.46e-05	0.00173	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	9.33e-05	0.0017	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—FOXM1—lung cancer	9.16e-05	0.00167	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	9.02e-05	0.00164	CbGpPWpGaD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—AVP—lung cancer	8.68e-05	0.00158	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—lung cancer	8.67e-05	0.00158	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	8.55e-05	0.00156	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	8.55e-05	0.00156	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1B—lung cancer	8.49e-05	0.00155	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCC3—lung cancer	8.39e-05	0.00153	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—lung cancer	8.35e-05	0.00152	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—lung cancer	8.1e-05	0.00148	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—lung cancer	8.09e-05	0.00148	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	8e-05	0.00146	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—lung cancer	7.91e-05	0.00144	CbGpPWpGaD
Sparfloxacin—TOP2A—Cytarabine—Gemcitabine—lung cancer	7.9e-05	0.0175	CbGdCrCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—GNG11—lung cancer	7.61e-05	0.00139	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—PPP2R1B—lung cancer	7.59e-05	0.00138	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	7.54e-05	0.00137	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	7.5e-05	0.00137	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—TERT—lung cancer	7.4e-05	0.00135	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—lung cancer	7.33e-05	0.00134	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL10—lung cancer	7.27e-05	0.00133	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—LMNA—lung cancer	7.24e-05	0.00132	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	7.16e-05	0.00131	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—lung cancer	7.09e-05	0.00129	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—lung cancer	7.08e-05	0.00129	CbGpPWpGaD
Sparfloxacin—Pneumonia—Methotrexate—lung cancer	7.04e-05	0.000428	CcSEcCtD
Sparfloxacin—Anorexia—Paclitaxel—lung cancer	6.97e-05	0.000423	CcSEcCtD
Sparfloxacin—Pain—Cisplatin—lung cancer	6.96e-05	0.000423	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Methotrexate—lung cancer	6.94e-05	0.000422	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Doxorubicin—lung cancer	6.94e-05	0.000421	CcSEcCtD
Sparfloxacin—Vomiting—Vinorelbine—lung cancer	6.91e-05	0.00042	CcSEcCtD
Sparfloxacin—Body temperature increased—Gemcitabine—lung cancer	6.9e-05	0.000419	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—lung cancer	6.86e-05	0.00125	CbGpPWpGaD
Sparfloxacin—Rash—Vinorelbine—lung cancer	6.85e-05	0.000416	CcSEcCtD
Sparfloxacin—Dermatitis—Vinorelbine—lung cancer	6.85e-05	0.000416	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ADCY1—lung cancer	6.84e-05	0.00125	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG2—lung cancer	6.84e-05	0.00125	CbGpPWpGaD
Sparfloxacin—Stomatitis—Methotrexate—lung cancer	6.82e-05	0.000415	CcSEcCtD
Sparfloxacin—Headache—Vinorelbine—lung cancer	6.81e-05	0.000414	CcSEcCtD
Sparfloxacin—Conjunctivitis—Methotrexate—lung cancer	6.81e-05	0.000413	CcSEcCtD
Sparfloxacin—Asthma—Doxorubicin—lung cancer	6.8e-05	0.000413	CcSEcCtD
Sparfloxacin—TOP2A—Daunorubicin—Doxorubicin—lung cancer	6.78e-05	0.015	CbGdCrCtD
Sparfloxacin—TOP2A—Epirubicin—Doxorubicin—lung cancer	6.78e-05	0.015	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Doxorubicin—lung cancer	6.78e-05	0.015	CbGdCrCtD
Sparfloxacin—ABCB1—Allograft Rejection—FASLG—lung cancer	6.76e-05	0.00123	CbGpPWpGaD
Sparfloxacin—Sweating—Methotrexate—lung cancer	6.71e-05	0.000408	CcSEcCtD
Sparfloxacin—Palpitations—Docetaxel—lung cancer	6.71e-05	0.000408	CcSEcCtD
Sparfloxacin—Feeling abnormal—Cisplatin—lung cancer	6.71e-05	0.000407	CcSEcCtD
Sparfloxacin—Paraesthesia—Etoposide—lung cancer	6.69e-05	0.000407	CcSEcCtD
Sparfloxacin—Haematuria—Methotrexate—lung cancer	6.68e-05	0.000406	CcSEcCtD
Sparfloxacin—Pancreatitis—Doxorubicin—lung cancer	6.67e-05	0.000405	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Paclitaxel—lung cancer	6.66e-05	0.000405	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	6.65e-05	0.00121	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Etoposide—lung cancer	6.65e-05	0.000404	CcSEcCtD
Sparfloxacin—Somnolence—Etoposide—lung cancer	6.63e-05	0.000403	CcSEcCtD
Sparfloxacin—Cough—Docetaxel—lung cancer	6.62e-05	0.000402	CcSEcCtD
Sparfloxacin—Angina pectoris—Doxorubicin—lung cancer	6.62e-05	0.000402	CcSEcCtD
Sparfloxacin—Insomnia—Paclitaxel—lung cancer	6.61e-05	0.000402	CcSEcCtD
Sparfloxacin—Epistaxis—Methotrexate—lung cancer	6.6e-05	0.000401	CcSEcCtD
Sparfloxacin—Hypersensitivity—Irinotecan—lung cancer	6.6e-05	0.000401	CcSEcCtD
Sparfloxacin—Convulsion—Docetaxel—lung cancer	6.58e-05	0.0004	CcSEcCtD
Sparfloxacin—Paraesthesia—Paclitaxel—lung cancer	6.56e-05	0.000399	CcSEcCtD
Sparfloxacin—Hypertension—Docetaxel—lung cancer	6.55e-05	0.000398	CcSEcCtD
Sparfloxacin—Bronchitis—Doxorubicin—lung cancer	6.54e-05	0.000397	CcSEcCtD
Sparfloxacin—Agranulocytosis—Methotrexate—lung cancer	6.53e-05	0.000397	CcSEcCtD
Sparfloxacin—Dyspnoea—Paclitaxel—lung cancer	6.52e-05	0.000396	CcSEcCtD
Sparfloxacin—Somnolence—Paclitaxel—lung cancer	6.5e-05	0.000395	CcSEcCtD
Sparfloxacin—Decreased appetite—Etoposide—lung cancer	6.48e-05	0.000394	CcSEcCtD
Sparfloxacin—Arthralgia—Docetaxel—lung cancer	6.46e-05	0.000393	CcSEcCtD
Sparfloxacin—Chest pain—Docetaxel—lung cancer	6.46e-05	0.000393	CcSEcCtD
Sparfloxacin—Myalgia—Docetaxel—lung cancer	6.46e-05	0.000393	CcSEcCtD
Sparfloxacin—Pancytopenia—Doxorubicin—lung cancer	6.46e-05	0.000392	CcSEcCtD
Sparfloxacin—Nausea—Vinorelbine—lung cancer	6.45e-05	0.000392	CcSEcCtD
Sparfloxacin—Dyspepsia—Paclitaxel—lung cancer	6.43e-05	0.000391	CcSEcCtD
Sparfloxacin—Body temperature increased—Cisplatin—lung cancer	6.43e-05	0.000391	CcSEcCtD
Sparfloxacin—Asthenia—Irinotecan—lung cancer	6.43e-05	0.000391	CcSEcCtD
Sparfloxacin—Constipation—Etoposide—lung cancer	6.37e-05	0.000387	CcSEcCtD
Sparfloxacin—Pain—Etoposide—lung cancer	6.37e-05	0.000387	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	6.37e-05	0.00116	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—TF—lung cancer	6.36e-05	0.00116	CbGpPWpGaD
Sparfloxacin—Dysuria—Doxorubicin—lung cancer	6.36e-05	0.000386	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC34A2—lung cancer	6.36e-05	0.00116	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Paclitaxel—lung cancer	6.35e-05	0.000386	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	6.35e-05	0.00116	CbGpPWpGaD
Sparfloxacin—Dry mouth—Docetaxel—lung cancer	6.32e-05	0.000384	CcSEcCtD
Sparfloxacin—Haemoglobin—Methotrexate—lung cancer	6.32e-05	0.000384	CcSEcCtD
Sparfloxacin—Hepatitis—Methotrexate—lung cancer	6.28e-05	0.000382	CcSEcCtD
Sparfloxacin—Haemorrhage—Methotrexate—lung cancer	6.28e-05	0.000382	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	6.28e-05	0.00115	CbGpPWpGaD
Sparfloxacin—Asthenia—Gemcitabine—lung cancer	6.26e-05	0.000381	CcSEcCtD
Sparfloxacin—Pain—Paclitaxel—lung cancer	6.25e-05	0.00038	CcSEcCtD
Sparfloxacin—Constipation—Paclitaxel—lung cancer	6.25e-05	0.00038	CcSEcCtD
Sparfloxacin—Confusional state—Docetaxel—lung cancer	6.25e-05	0.000379	CcSEcCtD
Sparfloxacin—Pharyngitis—Methotrexate—lung cancer	6.24e-05	0.000379	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Doxorubicin—lung cancer	6.21e-05	0.000377	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Docetaxel—lung cancer	6.2e-05	0.000376	CcSEcCtD
Sparfloxacin—Pruritus—Gemcitabine—lung cancer	6.18e-05	0.000375	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	6.15e-05	0.00112	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Etoposide—lung cancer	6.14e-05	0.000373	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCC3—lung cancer	6.14e-05	0.00112	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Irinotecan—lung cancer	6.13e-05	0.000373	CcSEcCtD
Sparfloxacin—Pneumonia—Doxorubicin—lung cancer	6.1e-05	0.00037	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Etoposide—lung cancer	6.1e-05	0.00037	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Docetaxel—lung cancer	6.07e-05	0.000368	CcSEcCtD
Sparfloxacin—Tachycardia—Docetaxel—lung cancer	6.05e-05	0.000367	CcSEcCtD
Sparfloxacin—Feeling abnormal—Paclitaxel—lung cancer	6.02e-05	0.000366	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	6.01e-05	0.000365	CcSEcCtD
Sparfloxacin—Hypersensitivity—Cisplatin—lung cancer	5.99e-05	0.000364	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Paclitaxel—lung cancer	5.98e-05	0.000363	CcSEcCtD
Sparfloxacin—Diarrhoea—Gemcitabine—lung cancer	5.97e-05	0.000363	CcSEcCtD
Sparfloxacin—Erythema multiforme—Methotrexate—lung cancer	5.94e-05	0.000361	CcSEcCtD
Sparfloxacin—Dizziness—Irinotecan—lung cancer	5.93e-05	0.00036	CcSEcCtD
Sparfloxacin—Urticaria—Etoposide—lung cancer	5.92e-05	0.00036	CcSEcCtD
Sparfloxacin—Jaundice—Doxorubicin—lung cancer	5.91e-05	0.000359	CcSEcCtD
Sparfloxacin—Stomatitis—Doxorubicin—lung cancer	5.91e-05	0.000359	CcSEcCtD
Sparfloxacin—Anorexia—Docetaxel—lung cancer	5.91e-05	0.000359	CcSEcCtD
Sparfloxacin—Body temperature increased—Etoposide—lung cancer	5.89e-05	0.000358	CcSEcCtD
Sparfloxacin—Abdominal pain—Etoposide—lung cancer	5.89e-05	0.000358	CcSEcCtD
Sparfloxacin—Urinary tract infection—Doxorubicin—lung cancer	5.89e-05	0.000358	CcSEcCtD
Sparfloxacin—Conjunctivitis—Doxorubicin—lung cancer	5.89e-05	0.000358	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—lung cancer	5.88e-05	0.00107	CbGpPWpGaD
Sparfloxacin—Tinnitus—Methotrexate—lung cancer	5.86e-05	0.000356	CcSEcCtD
Sparfloxacin—Asthenia—Cisplatin—lung cancer	5.84e-05	0.000355	CcSEcCtD
Sparfloxacin—Sweating—Doxorubicin—lung cancer	5.81e-05	0.000353	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	5.81e-05	0.00106	CbGpPWpGaD
Sparfloxacin—Urticaria—Paclitaxel—lung cancer	5.81e-05	0.000353	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—lung cancer	5.78e-05	0.00105	CbGpPWpGaD
Sparfloxacin—Haematuria—Doxorubicin—lung cancer	5.78e-05	0.000351	CcSEcCtD
Sparfloxacin—Body temperature increased—Paclitaxel—lung cancer	5.78e-05	0.000351	CcSEcCtD
Sparfloxacin—Abdominal pain—Paclitaxel—lung cancer	5.78e-05	0.000351	CcSEcCtD
Sparfloxacin—Epistaxis—Doxorubicin—lung cancer	5.72e-05	0.000347	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	5.7e-05	0.00104	CbGpPWpGaD
Sparfloxacin—Vomiting—Irinotecan—lung cancer	5.7e-05	0.000346	CcSEcCtD
Sparfloxacin—Sinusitis—Doxorubicin—lung cancer	5.69e-05	0.000346	CcSEcCtD
Sparfloxacin—TOP2A—Azacitidine—Gemcitabine—lung cancer	5.66e-05	0.0125	CbGdCrCtD
Sparfloxacin—Agranulocytosis—Doxorubicin—lung cancer	5.66e-05	0.000344	CcSEcCtD
Sparfloxacin—Rash—Irinotecan—lung cancer	5.65e-05	0.000343	CcSEcCtD
Sparfloxacin—Dermatitis—Irinotecan—lung cancer	5.65e-05	0.000343	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Docetaxel—lung cancer	5.64e-05	0.000343	CcSEcCtD
Sparfloxacin—Chills—Methotrexate—lung cancer	5.64e-05	0.000343	CcSEcCtD
Sparfloxacin—Headache—Irinotecan—lung cancer	5.61e-05	0.000341	CcSEcCtD
Sparfloxacin—Insomnia—Docetaxel—lung cancer	5.6e-05	0.00034	CcSEcCtD
Sparfloxacin—Diarrhoea—Cisplatin—lung cancer	5.57e-05	0.000338	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—GNG11—lung cancer	5.56e-05	0.00101	CbGpPWpGaD
Sparfloxacin—Paraesthesia—Docetaxel—lung cancer	5.56e-05	0.000338	CcSEcCtD
Sparfloxacin—Alopecia—Methotrexate—lung cancer	5.55e-05	0.000337	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	5.55e-05	0.00101	CbGpPWpGaD
Sparfloxacin—Vomiting—Gemcitabine—lung cancer	5.55e-05	0.000337	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	5.54e-05	0.00101	CbGpPWpGaD
Sparfloxacin—Dyspnoea—Docetaxel—lung cancer	5.52e-05	0.000336	CcSEcCtD
Sparfloxacin—Somnolence—Docetaxel—lung cancer	5.51e-05	0.000335	CcSEcCtD
Sparfloxacin—Rash—Gemcitabine—lung cancer	5.5e-05	0.000334	CcSEcCtD
Sparfloxacin—Dermatitis—Gemcitabine—lung cancer	5.5e-05	0.000334	CcSEcCtD
Sparfloxacin—Hypersensitivity—Etoposide—lung cancer	5.49e-05	0.000334	CcSEcCtD
Sparfloxacin—Haemoglobin—Doxorubicin—lung cancer	5.47e-05	0.000332	CcSEcCtD
Sparfloxacin—Headache—Gemcitabine—lung cancer	5.47e-05	0.000332	CcSEcCtD
Sparfloxacin—Rhinitis—Doxorubicin—lung cancer	5.46e-05	0.000331	CcSEcCtD
Sparfloxacin—Dyspepsia—Docetaxel—lung cancer	5.45e-05	0.000331	CcSEcCtD
Sparfloxacin—Hepatitis—Doxorubicin—lung cancer	5.44e-05	0.000331	CcSEcCtD
Sparfloxacin—Haemorrhage—Doxorubicin—lung cancer	5.44e-05	0.000331	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Doxorubicin—lung cancer	5.41e-05	0.000329	CcSEcCtD
Sparfloxacin—Pharyngitis—Doxorubicin—lung cancer	5.4e-05	0.000328	CcSEcCtD
Sparfloxacin—Decreased appetite—Docetaxel—lung cancer	5.39e-05	0.000327	CcSEcCtD
Sparfloxacin—Hypersensitivity—Paclitaxel—lung cancer	5.38e-05	0.000327	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	5.37e-05	0.000979	CbGpPWpGaD
Sparfloxacin—Oedema peripheral—Doxorubicin—lung cancer	5.36e-05	0.000326	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	5.36e-05	0.000977	CbGpPWpGaD
Sparfloxacin—Dysgeusia—Methotrexate—lung cancer	5.36e-05	0.000325	CcSEcCtD
Sparfloxacin—Asthenia—Etoposide—lung cancer	5.35e-05	0.000325	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—lung cancer	5.34e-05	0.000973	CbGpPWpGaD
Sparfloxacin—Nausea—Irinotecan—lung cancer	5.32e-05	0.000323	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—JUN—lung cancer	5.32e-05	0.00097	CbGpPWpGaD
Sparfloxacin—Pain—Docetaxel—lung cancer	5.3e-05	0.000322	CcSEcCtD
Sparfloxacin—Constipation—Docetaxel—lung cancer	5.3e-05	0.000322	CcSEcCtD
Sparfloxacin—Back pain—Methotrexate—lung cancer	5.29e-05	0.000321	CcSEcCtD
Sparfloxacin—Pruritus—Etoposide—lung cancer	5.27e-05	0.00032	CcSEcCtD
Sparfloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—lung cancer	5.26e-05	0.000958	CbGpPWpGaD
Sparfloxacin—Asthenia—Paclitaxel—lung cancer	5.24e-05	0.000319	CcSEcCtD
Sparfloxacin—Nausea—Gemcitabine—lung cancer	5.19e-05	0.000315	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	5.18e-05	0.000944	CbGpPWpGaD
Sparfloxacin—Vomiting—Cisplatin—lung cancer	5.17e-05	0.000314	CcSEcCtD
Sparfloxacin—Pruritus—Paclitaxel—lung cancer	5.17e-05	0.000314	CcSEcCtD
Sparfloxacin—Erythema multiforme—Doxorubicin—lung cancer	5.15e-05	0.000313	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—PTEN—lung cancer	5.14e-05	0.000938	CbGpPWpGaD
Sparfloxacin—Rash—Cisplatin—lung cancer	5.13e-05	0.000312	CcSEcCtD
Sparfloxacin—Dermatitis—Cisplatin—lung cancer	5.13e-05	0.000311	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	5.11e-05	0.000932	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Docetaxel—lung cancer	5.11e-05	0.00031	CcSEcCtD
Sparfloxacin—Diarrhoea—Etoposide—lung cancer	5.1e-05	0.00031	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Methotrexate—lung cancer	5.08e-05	0.000308	CcSEcCtD
Sparfloxacin—Tinnitus—Doxorubicin—lung cancer	5.07e-05	0.000308	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Docetaxel—lung cancer	5.07e-05	0.000308	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—CASP8—lung cancer	5.03e-05	0.000917	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ADCY1—lung cancer	5e-05	0.000912	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCG2—lung cancer	5e-05	0.000912	CbGpPWpGaD
Sparfloxacin—Diarrhoea—Paclitaxel—lung cancer	5e-05	0.000304	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	4.97e-05	0.000906	CbGpPWpGaD
Sparfloxacin—Malaise—Methotrexate—lung cancer	4.93e-05	0.0003	CcSEcCtD
Sparfloxacin—Dizziness—Etoposide—lung cancer	4.93e-05	0.000299	CcSEcCtD
Sparfloxacin—Vertigo—Methotrexate—lung cancer	4.92e-05	0.000299	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	4.91e-05	0.000895	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—EP300—lung cancer	4.91e-05	0.000894	CbGpPWpGaD
Sparfloxacin—Body temperature increased—Docetaxel—lung cancer	4.9e-05	0.000298	CcSEcCtD
Sparfloxacin—Abdominal pain—Docetaxel—lung cancer	4.9e-05	0.000298	CcSEcCtD
Sparfloxacin—Chills—Doxorubicin—lung cancer	4.88e-05	0.000297	CcSEcCtD
Sparfloxacin—Arrhythmia—Doxorubicin—lung cancer	4.86e-05	0.000295	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	4.84e-05	0.000882	CbGpPWpGaD
Sparfloxacin—Dizziness—Paclitaxel—lung cancer	4.83e-05	0.000294	CcSEcCtD
Sparfloxacin—Nausea—Cisplatin—lung cancer	4.83e-05	0.000294	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—SLC22A18—lung cancer	4.82e-05	0.000878	CbGpPWpGaD
Sparfloxacin—Alopecia—Doxorubicin—lung cancer	4.81e-05	0.000292	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—lung cancer	4.8e-05	0.000875	CbGpPWpGaD
Sparfloxacin—Cough—Methotrexate—lung cancer	4.77e-05	0.00029	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—TYMS—lung cancer	4.77e-05	0.00087	CbGpPWpGaD
Sparfloxacin—Convulsion—Methotrexate—lung cancer	4.74e-05	0.000288	CcSEcCtD
Sparfloxacin—Vomiting—Etoposide—lung cancer	4.74e-05	0.000288	CcSEcCtD
Sparfloxacin—Rash—Etoposide—lung cancer	4.7e-05	0.000286	CcSEcCtD
Sparfloxacin—Dermatitis—Etoposide—lung cancer	4.7e-05	0.000285	CcSEcCtD
Sparfloxacin—Headache—Etoposide—lung cancer	4.67e-05	0.000284	CcSEcCtD
Sparfloxacin—Flatulence—Doxorubicin—lung cancer	4.67e-05	0.000284	CcSEcCtD
Sparfloxacin—Myalgia—Methotrexate—lung cancer	4.66e-05	0.000283	CcSEcCtD
Sparfloxacin—Chest pain—Methotrexate—lung cancer	4.66e-05	0.000283	CcSEcCtD
Sparfloxacin—Arthralgia—Methotrexate—lung cancer	4.66e-05	0.000283	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TF—lung cancer	4.65e-05	0.000848	CbGpPWpGaD
Sparfloxacin—Tension—Doxorubicin—lung cancer	4.65e-05	0.000282	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	4.65e-05	0.000847	CbGpPWpGaD
Sparfloxacin—Vomiting—Paclitaxel—lung cancer	4.65e-05	0.000282	CcSEcCtD
Sparfloxacin—Dysgeusia—Doxorubicin—lung cancer	4.64e-05	0.000282	CcSEcCtD
Sparfloxacin—Rash—Paclitaxel—lung cancer	4.61e-05	0.00028	CcSEcCtD
Sparfloxacin—Dermatitis—Paclitaxel—lung cancer	4.6e-05	0.00028	CcSEcCtD
Sparfloxacin—Discomfort—Methotrexate—lung cancer	4.6e-05	0.00028	CcSEcCtD
Sparfloxacin—Nervousness—Doxorubicin—lung cancer	4.6e-05	0.00028	CcSEcCtD
Sparfloxacin—Back pain—Doxorubicin—lung cancer	4.58e-05	0.000278	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	4.58e-05	0.000835	CbGpPWpGaD
Sparfloxacin—Headache—Paclitaxel—lung cancer	4.58e-05	0.000278	CcSEcCtD
Sparfloxacin—Hypersensitivity—Docetaxel—lung cancer	4.56e-05	0.000277	CcSEcCtD
Sparfloxacin—Confusional state—Methotrexate—lung cancer	4.5e-05	0.000274	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Methotrexate—lung cancer	4.47e-05	0.000271	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	4.45e-05	0.000812	CbGpPWpGaD
Sparfloxacin—Asthenia—Docetaxel—lung cancer	4.44e-05	0.00027	CcSEcCtD
Sparfloxacin—Nausea—Etoposide—lung cancer	4.43e-05	0.000269	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—AVP—lung cancer	4.41e-05	0.000804	CbGpPWpGaD
Sparfloxacin—Ill-defined disorder—Doxorubicin—lung cancer	4.4e-05	0.000267	CcSEcCtD
Sparfloxacin—Pruritus—Docetaxel—lung cancer	4.38e-05	0.000266	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Methotrexate—lung cancer	4.37e-05	0.000266	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	4.36e-05	0.000794	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—lung cancer	4.35e-05	0.000794	CbGpPWpGaD
Sparfloxacin—Agitation—Doxorubicin—lung cancer	4.35e-05	0.000264	CcSEcCtD
Sparfloxacin—Nausea—Paclitaxel—lung cancer	4.34e-05	0.000264	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Methotrexate—lung cancer	4.32e-05	0.000262	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—BIRC5—lung cancer	4.29e-05	0.000782	CbGpPWpGaD
Sparfloxacin—Malaise—Doxorubicin—lung cancer	4.27e-05	0.00026	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—lung cancer	4.27e-05	0.000778	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—JUN—lung cancer	4.27e-05	0.000778	CbGpPWpGaD
Sparfloxacin—Vertigo—Doxorubicin—lung cancer	4.26e-05	0.000259	CcSEcCtD
Sparfloxacin—Anorexia—Methotrexate—lung cancer	4.26e-05	0.000259	CcSEcCtD
Sparfloxacin—Diarrhoea—Docetaxel—lung cancer	4.24e-05	0.000258	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	4.22e-05	0.000769	CbGpPWpGaD
Sparfloxacin—Palpitations—Doxorubicin—lung cancer	4.19e-05	0.000254	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—TERT—lung cancer	4.16e-05	0.000758	CbGpPWpGaD
Sparfloxacin—Cough—Doxorubicin—lung cancer	4.13e-05	0.000251	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	4.12e-05	0.00075	CbGpPWpGaD
Sparfloxacin—Convulsion—Doxorubicin—lung cancer	4.1e-05	0.000249	CcSEcCtD
Sparfloxacin—Dizziness—Docetaxel—lung cancer	4.1e-05	0.000249	CcSEcCtD
Sparfloxacin—Hypertension—Doxorubicin—lung cancer	4.09e-05	0.000248	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Methotrexate—lung cancer	4.07e-05	0.000247	CcSEcCtD
Sparfloxacin—Insomnia—Methotrexate—lung cancer	4.04e-05	0.000245	CcSEcCtD
Sparfloxacin—Myalgia—Doxorubicin—lung cancer	4.03e-05	0.000245	CcSEcCtD
Sparfloxacin—Chest pain—Doxorubicin—lung cancer	4.03e-05	0.000245	CcSEcCtD
Sparfloxacin—Arthralgia—Doxorubicin—lung cancer	4.03e-05	0.000245	CcSEcCtD
Sparfloxacin—Anxiety—Doxorubicin—lung cancer	4.02e-05	0.000244	CcSEcCtD
Sparfloxacin—Paraesthesia—Methotrexate—lung cancer	4.01e-05	0.000244	CcSEcCtD
Sparfloxacin—Discomfort—Doxorubicin—lung cancer	3.98e-05	0.000242	CcSEcCtD
Sparfloxacin—Dyspnoea—Methotrexate—lung cancer	3.98e-05	0.000242	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—CXCL8—lung cancer	3.98e-05	0.000725	CbGpPWpGaD
Sparfloxacin—Somnolence—Methotrexate—lung cancer	3.97e-05	0.000241	CcSEcCtD
Sparfloxacin—Dry mouth—Doxorubicin—lung cancer	3.94e-05	0.00024	CcSEcCtD
Sparfloxacin—Vomiting—Docetaxel—lung cancer	3.94e-05	0.000239	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—EP300—lung cancer	3.94e-05	0.000718	CbGpPWpGaD
Sparfloxacin—Dyspepsia—Methotrexate—lung cancer	3.93e-05	0.000239	CcSEcCtD
Sparfloxacin—Rash—Docetaxel—lung cancer	3.91e-05	0.000237	CcSEcCtD
Sparfloxacin—Dermatitis—Docetaxel—lung cancer	3.9e-05	0.000237	CcSEcCtD
Sparfloxacin—Confusional state—Doxorubicin—lung cancer	3.9e-05	0.000237	CcSEcCtD
Sparfloxacin—Decreased appetite—Methotrexate—lung cancer	3.88e-05	0.000236	CcSEcCtD
Sparfloxacin—Headache—Docetaxel—lung cancer	3.88e-05	0.000236	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Doxorubicin—lung cancer	3.87e-05	0.000235	CcSEcCtD
Sparfloxacin—Pain—Methotrexate—lung cancer	3.82e-05	0.000232	CcSEcCtD
Sparfloxacin—ABCB1—Allograft Rejection—CASP3—lung cancer	3.81e-05	0.000694	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—IL2—lung cancer	3.8e-05	0.000693	CbGpPWpGaD
Sparfloxacin—Thrombocytopenia—Doxorubicin—lung cancer	3.79e-05	0.00023	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	3.78e-05	0.000689	CbGpPWpGaD
Sparfloxacin—Tachycardia—Doxorubicin—lung cancer	3.77e-05	0.000229	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Doxorubicin—lung cancer	3.74e-05	0.000227	CcSEcCtD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	3.73e-05	0.00068	CbGpPWpGaD
Sparfloxacin—Anorexia—Doxorubicin—lung cancer	3.69e-05	0.000224	CcSEcCtD
Sparfloxacin—Nausea—Docetaxel—lung cancer	3.68e-05	0.000224	CcSEcCtD
Sparfloxacin—Feeling abnormal—Methotrexate—lung cancer	3.68e-05	0.000224	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	3.66e-05	0.000667	CbGpPWpGaD
Sparfloxacin—Gastrointestinal pain—Methotrexate—lung cancer	3.65e-05	0.000222	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	3.63e-05	0.000662	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RB1—lung cancer	3.62e-05	0.00066	CbGpPWpGaD
Sparfloxacin—Urticaria—Methotrexate—lung cancer	3.55e-05	0.000215	CcSEcCtD
Sparfloxacin—Body temperature increased—Methotrexate—lung cancer	3.53e-05	0.000214	CcSEcCtD
Sparfloxacin—Abdominal pain—Methotrexate—lung cancer	3.53e-05	0.000214	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.52e-05	0.000214	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—TP53—lung cancer	3.51e-05	0.00064	CbGpPWpGaD
Sparfloxacin—Insomnia—Doxorubicin—lung cancer	3.5e-05	0.000212	CcSEcCtD
Sparfloxacin—Paraesthesia—Doxorubicin—lung cancer	3.47e-05	0.000211	CcSEcCtD
Sparfloxacin—Dyspnoea—Doxorubicin—lung cancer	3.45e-05	0.000209	CcSEcCtD
Sparfloxacin—Somnolence—Doxorubicin—lung cancer	3.44e-05	0.000209	CcSEcCtD
Sparfloxacin—Dyspepsia—Doxorubicin—lung cancer	3.4e-05	0.000207	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—APOA1—lung cancer	3.37e-05	0.000615	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Doxorubicin—lung cancer	3.36e-05	0.000204	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	3.34e-05	0.000608	CbGpPWpGaD
Sparfloxacin—Constipation—Doxorubicin—lung cancer	3.31e-05	0.000201	CcSEcCtD
Sparfloxacin—Pain—Doxorubicin—lung cancer	3.31e-05	0.000201	CcSEcCtD
Sparfloxacin—Hypersensitivity—Methotrexate—lung cancer	3.29e-05	0.0002	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—AZIN2—lung cancer	3.25e-05	0.000593	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—COL4A3BP—lung cancer	3.25e-05	0.000593	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—RB1—lung cancer	3.24e-05	0.00059	CbGpPWpGaD
Sparfloxacin—ABCB1—Allograft Rejection—VEGFA—lung cancer	3.23e-05	0.000589	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—AVP—lung cancer	3.22e-05	0.000588	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—IL6—lung cancer	3.21e-05	0.000586	CbGpPWpGaD
Sparfloxacin—Asthenia—Methotrexate—lung cancer	3.2e-05	0.000195	CcSEcCtD
Sparfloxacin—Feeling abnormal—Doxorubicin—lung cancer	3.19e-05	0.000194	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—lung cancer	3.18e-05	0.00058	CbGpPWpGaD
Sparfloxacin—Gastrointestinal pain—Doxorubicin—lung cancer	3.16e-05	0.000192	CcSEcCtD
Sparfloxacin—Pruritus—Methotrexate—lung cancer	3.16e-05	0.000192	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—lung cancer	3.12e-05	0.000569	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	3.09e-05	0.000563	CbGpPWpGaD
Sparfloxacin—Urticaria—Doxorubicin—lung cancer	3.07e-05	0.000187	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.07e-05	0.00056	CbGpPWpGaD
Sparfloxacin—Abdominal pain—Doxorubicin—lung cancer	3.06e-05	0.000186	CcSEcCtD
Sparfloxacin—Body temperature increased—Doxorubicin—lung cancer	3.06e-05	0.000186	CcSEcCtD
Sparfloxacin—Diarrhoea—Methotrexate—lung cancer	3.06e-05	0.000186	CcSEcCtD
Sparfloxacin—Dizziness—Methotrexate—lung cancer	2.95e-05	0.000179	CcSEcCtD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	2.89e-05	0.000526	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—lung cancer	2.85e-05	0.00052	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Doxorubicin—lung cancer	2.85e-05	0.000173	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CDKN2A—lung cancer	2.84e-05	0.000519	CbGpPWpGaD
Sparfloxacin—Vomiting—Methotrexate—lung cancer	2.84e-05	0.000172	CcSEcCtD
Sparfloxacin—Rash—Methotrexate—lung cancer	2.82e-05	0.000171	CcSEcCtD
Sparfloxacin—Dermatitis—Methotrexate—lung cancer	2.81e-05	0.000171	CcSEcCtD
Sparfloxacin—Headache—Methotrexate—lung cancer	2.8e-05	0.00017	CcSEcCtD
Sparfloxacin—Asthenia—Doxorubicin—lung cancer	2.77e-05	0.000169	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—ATP5H—lung cancer	2.77e-05	0.000504	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MDM2—lung cancer	2.76e-05	0.000503	CbGpPWpGaD
Sparfloxacin—Pruritus—Doxorubicin—lung cancer	2.74e-05	0.000166	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—lung cancer	2.69e-05	0.00049	CbGpPWpGaD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—lung cancer	2.67e-05	0.000487	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	2.67e-05	0.000486	CbGpPWpGaD
Sparfloxacin—Nausea—Methotrexate—lung cancer	2.65e-05	0.000161	CcSEcCtD
Sparfloxacin—Diarrhoea—Doxorubicin—lung cancer	2.65e-05	0.000161	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	2.63e-05	0.00048	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	2.62e-05	0.000477	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—lung cancer	2.6e-05	0.000474	CbGpPWpGaD
Sparfloxacin—Dizziness—Doxorubicin—lung cancer	2.56e-05	0.000155	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	2.48e-05	0.000452	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—EP300—lung cancer	2.47e-05	0.000451	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	2.47e-05	0.00045	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PLBD1—lung cancer	2.47e-05	0.00045	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—APOA1—lung cancer	2.47e-05	0.000449	CbGpPWpGaD
Sparfloxacin—Vomiting—Doxorubicin—lung cancer	2.46e-05	0.000149	CcSEcCtD
Sparfloxacin—Rash—Doxorubicin—lung cancer	2.44e-05	0.000148	CcSEcCtD
Sparfloxacin—Dermatitis—Doxorubicin—lung cancer	2.44e-05	0.000148	CcSEcCtD
Sparfloxacin—Headache—Doxorubicin—lung cancer	2.42e-05	0.000147	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—lung cancer	2.42e-05	0.00044	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CCND1—lung cancer	2.4e-05	0.000438	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	2.38e-05	0.000434	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	2.36e-05	0.00043	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	2.35e-05	0.000429	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	2.35e-05	0.000429	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDKN1A—lung cancer	2.33e-05	0.000424	CbGpPWpGaD
Sparfloxacin—Nausea—Doxorubicin—lung cancer	2.3e-05	0.00014	CcSEcCtD
Sparfloxacin—ABCB1—Metabolism—HSD17B10—lung cancer	2.26e-05	0.000411	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	2.22e-05	0.000404	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—EP300—lung cancer	2.21e-05	0.000403	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	2.19e-05	0.000399	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	2.16e-05	0.000393	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.1e-05	0.000383	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CKB—lung cancer	2.1e-05	0.000382	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.09e-05	0.000381	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.09e-05	0.00038	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.07e-05	0.000377	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.02e-05	0.000369	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MAPK3—lung cancer	1.98e-05	0.000361	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CNDP2—lung cancer	1.97e-05	0.000359	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM2—lung cancer	1.97e-05	0.000359	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—ALB—lung cancer	1.95e-05	0.000356	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MYC—lung cancer	1.93e-05	0.000351	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—MTMR3—lung cancer	1.92e-05	0.00035	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.88e-05	0.000342	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PGAM1—lung cancer	1.87e-05	0.000341	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.83e-05	0.000333	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.82e-05	0.000333	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP2A7—lung cancer	1.78e-05	0.000325	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.77e-05	0.000322	CbGpPWpGaD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—lung cancer	1.77e-05	0.000322	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.76e-05	0.000322	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—SDC4—lung cancer	1.75e-05	0.000318	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.68e-05	0.000307	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.64e-05	0.000298	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.59e-05	0.000291	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—RRM1—lung cancer	1.59e-05	0.00029	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA3—lung cancer	1.59e-05	0.00029	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TP53—lung cancer	1.58e-05	0.000289	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.52e-05	0.000276	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.51e-05	0.000275	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—B4GALT5—lung cancer	1.49e-05	0.000272	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.47e-05	0.000267	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA4—lung cancer	1.45e-05	0.000265	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.43e-05	0.000261	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA2—lung cancer	1.42e-05	0.000258	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTA1—lung cancer	1.37e-05	0.000249	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.36e-05	0.000247	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCC3—lung cancer	1.35e-05	0.000246	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKR1C1—lung cancer	1.31e-05	0.000239	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—UGT1A1—lung cancer	1.27e-05	0.000232	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.24e-05	0.000227	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GNG11—lung cancer	1.23e-05	0.000223	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.2e-05	0.00022	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALDOA—lung cancer	1.17e-05	0.000213	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.16e-05	0.000211	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NCOA3—lung cancer	1.13e-05	0.000206	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ADCY1—lung cancer	1.1e-05	0.000201	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ABCG2—lung cancer	1.1e-05	0.000201	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ENO2—lung cancer	1.08e-05	0.000197	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—HPGDS—lung cancer	1.08e-05	0.000197	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PPP2R1B—lung cancer	1.07e-05	0.000196	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTT1—lung cancer	1.05e-05	0.000191	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP2A6—lung cancer	1.04e-05	0.000189	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GCLC—lung cancer	1.04e-05	0.000189	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.02e-05	0.000185	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ENO1—lung cancer	9.82e-06	0.000179	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	9.81e-06	0.000179	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	9.18e-06	0.000167	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP2E1—lung cancer	8.81e-06	0.000161	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NQO1—lung cancer	8.71e-06	0.000159	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	8.31e-06	0.000151	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—STK11—lung cancer	7.85e-06	0.000143	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTP1—lung cancer	7.26e-06	0.000132	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CAT—lung cancer	7.07e-06	0.000129	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—TYMS—lung cancer	6.75e-06	0.000123	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTM1—lung cancer	6.67e-06	0.000122	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP1A1—lung cancer	6.33e-06	0.000115	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ERCC2—lung cancer	6.28e-06	0.000114	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—APOA1—lung cancer	5.43e-06	9.9e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CG—lung cancer	4.96e-06	9.03e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—POMC—lung cancer	4.72e-06	8.6e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CREBBP—lung cancer	4.6e-06	8.38e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CD—lung cancer	4.36e-06	7.94e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ALB—lung cancer	4.3e-06	7.84e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CB—lung cancer	3.8e-06	6.92e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS2—lung cancer	3.76e-06	6.86e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTEN—lung cancer	3.28e-06	5.98e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—EP300—lung cancer	3.13e-06	5.7e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PIK3CA—lung cancer	2.32e-06	4.22e-05	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—AKT1—lung cancer	1.89e-06	3.45e-05	CbGpPWpGaD
